IQV
Price
$245.82Alerts
Change
-$4.73 (-1.89%)
Updated
Nov 20 closing price
Capitalization
44.74B
81 days until earnings call
Intraday BUY SELL Signals
STAA
Price
$24.22Alerts
Change
-$0.81 (-3.24%)
Updated
Nov 20 closing price
Capitalization
1.26B
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IQV vs STAA

IQV vs STAA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IQV vs. STAA commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Hold and STAA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IQV with price predictions
Nov 20, 2026

IQV in downward trend: price dove below 50-day moving average on November 13, 2026

IQV moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 20 of 27 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IQV as a result. In 50 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for IQV turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 21 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

The 10-day moving average for IQV crossed bearishly below the 50-day moving average on November 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

IQV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.251) is normal, around the industry mean (67.298). P/E Ratio (33.477) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
a Summary for STAA with price predictions
Nov 20, 2026

STAA in -4.46% downward trend, sliding for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where STAA declined for three days, in 288 of 333 cases, the price declined further within the following month. The odds of a continued downward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for STAA moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 19 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STAA as a result. In 89 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for STAA turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 39 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

STAA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 68 cases where STAA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

STAA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for STAA crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 43%.

Following a +12.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where STAA advanced for three days, in 197 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 82 of 139 cases where STAA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. STAA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.460) is normal, around the industry mean (4.964). STAA's P/E Ratio (315.125) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (2.060) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
IQV vs STAA: Fundamental Ratings
IQV
STAA
OUTLOOK RATING
1..100
7150
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4389
PRICE GROWTH RATING
1..100
4450
P/E GROWTH RATING
1..100
3142
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (77) in the Servicestothe Health Industry industry is in the same range as STAA (98) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.

IQV's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as STAA (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.

IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for STAA (89) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than STAA’s over the last 12 months.

IQV's Price Growth Rating (44) in the Servicestothe Health Industry industry is in the same range as STAA (50) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.

IQV's P/E Growth Rating (31) in the Servicestothe Health Industry industry is in the same range as STAA (42) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQVSTAA
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 13 days ago
62%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (IQV: $245.82 vs. STAA: $24.22)
Brand notoriety: IQV: Notable vs. STAA: Not notable
IQV represents the Medical Specialties, while STAA is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: IQV: 84% vs. STAA: 68%
Market capitalization -- IQV: $44.74B vs. STAA: $1.26B
IQV [@Medical Specialties] is valued at $44.74B. STAA’s [@Pharmaceuticals: Other] market capitalization is $1.26B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 1 FA rating(s) are green while STAA’s FA Score has 0 green FA rating(s).

  • IQV’s FA Score: 1 green, 4 red.
  • STAA’s FA Score: 0 green, 5 red.
According to our system of comparison, IQV is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while STAA’s TA Score has 5 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 5 bearish.
  • STAA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, STAA is a better buy in the short-term than IQV.

Price Growth

IQV (@Medical Specialties) experienced а -7.28% price change this week, while STAA (@Pharmaceuticals: Other) price change was -8.22% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -9.90%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was +16.33%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -7.82%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +4.34%.

Reported Earning Dates

IQV is expected to report earnings on Feb 11, 2027.

STAA is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Medical Specialties (-9.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-7.82% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-1.89%
CRL - IQV
71%
Closely correlated
-4.15%
TMO - IQV
67%
Closely correlated
-2.79%
RVTY - IQV
59%
Loosely correlated
-4.20%
A - IQV
58%
Loosely correlated
-2.83%
ICLR - IQV
54%
Loosely correlated
-1.92%
More

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with OFIX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-3.24%
OFIX - STAA
38%
Loosely correlated
-4.26%
CSTL - STAA
38%
Loosely correlated
-1.63%
IQV - STAA
37%
Loosely correlated
-1.89%
MTD - STAA
37%
Loosely correlated
-2.27%
FLGT - STAA
36%
Loosely correlated
-2.66%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCDL11.25-0.07
-0.62%
Nuveen Churchill Direct Lending Corp
GELS0.28N/A
-0.93%
Gelteq Ltd
RRR46.09-0.56
-1.20%
Red Rock Resorts
ICLR186.71-3.65
-1.92%
ICON plc
GLND1.65-0.24
-12.70%
Greenland Energy Company